News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Quantum Genomics reviewed its financial situation and announced that it has filed a declaration of cessation of payment today
Quantum Genomics files declaration of cessation of payments with Paris Commercial Court after failed fundraising negotiations, impacting subsidiary Exactcure -
COMMUNIQUÉ DE PRESSE
Quantum Genomics fait un point sur sa situation financière et annonce qu'elle a déposé ce jour une déclaration de cessation des paiements
Quantum Genomics annonce sa cessation de paiements et l'ouverture d'une procédure de liquidation judiciaire suite à des négociations de levée de fonds infructueuses -
-
-
COMMUNIQUÉ DE PRESSE
Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure's securities.
Quantum Genomics successfully approved transactions of reducing share capital and acquiring Exactcure's shares during Shareholders' General Meeting. Company now holds 100% of Exactcure, reinforcing market position
